The objective of this study was to identify the key circular RNAs (circRNAs) related to the development of colon cancer. High-throughput RNA sequencing on eight early-stage (ES) and eight later stage (LS) colon tumor tissues, and eight normal tissues, was performed. Differentially expressed circRNAs and differentially expressed mRNAs were identified. Functional enrichment analysis and the miRNA-circRNA-mRNA network were performed. In addition, the differential expression levels of key circRNAs were verified using real-time quantitative PCR (qPCR). In total, 408, 472, and 278 differentially expressed circRNAs were identified in ES versus normal control (N), LS versus N, and LS versus ES groups, respectively. Functional enrichment analysis showed that circ_052666 was significantly enriched in “extracellular matrix/receptor interaction”; circ_022743 was remarkably enriched in “neurotrophin signaling pathway”; and circ_004452 was observably enriched in “TGF-β signaling pathway.” Moreover, key miRNA-circRNA-mRNA relationships, such as hsa-miR-29b/c-3p-circ_052666-COL1A1 and hsa-miR-1294-circ_004452-left-right determination factor 1 (LEFTY1), were identified. Furthermore, qPCR showed consistent results with RNA sequencing. Our findings indicate that key circRNAs, such as circ_022743, circ_052666, and circ_004452, may be involved in colon cancer development, and could be used as potential biomarkers for the diagnosis and treatment of this disease.
Get full access to this article
View all access options for this article.
References
1.
AlowayedN., SalkerM.S., ZengN., SinghY., and LangF. (2016). LEFTY2 controls migration of human endometrial cancer cells via focal adhesion kinase activity (FAK) and miRNA-200a. Cell Physiol Biochem, 39, 815–826.
2.
AshburnerM., BallC.A., BlakeJ.A., BotsteinD., ButlerH., CherryJ.M., et al. (2000). Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet, 25, 25–29.
3.
Bachmayr-HeydaA., ReinerA.T., AuerK., SukhbaatarN., AustS., Bachleitner-HofmannT., et al. (2015). Correlation of circular RNA abundance with proliferation—exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep 5,8057.
4.
BellamN., and PascheB. (2010). Tgf-beta signaling alterations and colon cancer. Cancer Treat Res, 155, 85–103.
5.
BendardafR. (2006). Colorectal cancer: from epidemiology to current treatment. Libyan J Med, 1, 42–59.
6.
BenjaminiY., and HochbergY. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc, 57, 289–300.
7.
BolgerA.M., LohseM., and UsadelB. (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics, 30, 2114–2120.
8.
BrennerH., KloorM., and PoxC.P. (2014). Colorectal cancer. Lancet, 383, 1490–1502.
9.
CaiH., ChenH., YiT., DaimonC.M., BoyleJ.P., PeersC., et al. (2013). VennPlex—a novel Venn diagram program for comparing and visualizing datasets with differentially regulated datapoints. PLoS One 8,e53388.
10.
ChenE.Y., TanC.M., KouY., DuanQ., WangZ., MeirellesG.V., et al. (2013). Enrichr: interactive and collaborative HTML5 gene list enrichment; analysis tool. BMC Bioinformatics 14,128.
11.
ChopinV., LagadecC., ToillonR.A., and Le BourhisX. (2016). Neurotrophin signaling in cancer stem cells. Cell Mol Life Sci, 73, 1859–1870.
12.
ConnS.J., PillmanK.A., ToubiaJ., ConnV.M., SalmanidisM., PhillipsC.A., et al. (2015). The RNA binding protein quaking regulates formation of circRNAs. Cell, 160, 1125–1134.
13.
DaneseE., and MontagnanaM. (2017). Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers. Ann Transl Med 5,279.
14.
DingD., LiC., ZhaoT., LiD., YangL., and ZhangB. (2018). LncRNA H19/miR-29b-3p/PGRN axis promoted epithelial-mesenchymal transition of colorectal cancer cells by acting on Wnt signaling. Mol Cells, 41, 423–435.
15.
GlažarP., PapavasileiouP., and RajewskyN. (2014). circBase: a database for circular RNAs. RNA, 20, 1666–1670.
16.
GriffinN., FaulknerS., JoblingP., and HondermarckH. (2018). Targeting neurotrophin signaling in cancer: the renaissance. Pharmacol Res, 135, 12–17.
17.
HansenT.B., JensenT.I., ClausenB.H., BramsenJ.B., FinsenB., DamgaardC.K., et al. (2013). Natural RNA circles function as efficient microRNA sponges. Nature, 495, 384–388.
18.
HayashiM., NomotoS., HishidaM., InokawaY., KandaM., OkamuraY., et al. (2014). Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer 14,108.
JohnB., EnrightA.J., AravinA., TuschlT., SanderC., and MarksD.S. (2004). Human microRNA targets. PLoS Biol 2,e363.
21.
KanehisaM., and GotoS. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res, 28, 27–30.
22.
KentW.J., SugnetC.W., FureyT.S., RoskinK.M., PringleT.H., ZahlerA.M., et al. (2002). The human genome browser at UCSC. Genome Res, 12, 996–1006.
23.
KimD., PerteaG., TrapnellC., PimentelH., KelleyR., and SalzbergS.L. (2013). TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14,R36.
24.
KimD.K., ChaY., AhnH.J., KimG., and ParkK.S. (2014). Lefty1 and lefty2 control the balance between self-renewal and pluripotent differentiation of mouse embryonic stem cells. Stem Cells Dev, 23, 457–466.
25.
KohlM., WieseS., and WarscheidB. (2011). Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol, 696, 291–303.
26.
LiA.Q., SiJ.M., ShangY., GanL.H., GuoL., and ZhouT.H. (2010). [Construction of COL1A1 short hairpin RNA vector and its effect on cell proliferation and migration of gastric cancer cells]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 39, 257–263.
27.
LiJ., DingY., and LiA. (2016). Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer. World J Surg Oncol 14,297.
28.
LiZ., HuangC., BaoC., ChenL., LinM., WangX., et al. (2015). Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol, 22, 256–264.
29.
LiangX., LanC., JiaoG., FuW., LongX., AnY., et al. (2017a). Therapeutic inhibition of SGK1 suppresses colorectal cancer. Exp Mol Med 49,e399.
30.
LiangX., LanC., ZhouJ., FuW., LongX., AnY., et al. (2017b). Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer. J Cancer, 8, 2256–2262.
31.
LiuK., LiL., RusidanmuA., WangY., and LvX. (2015). Down-regulation of MiR-1294 is related to dismal prognosis of patients with esophageal squamous cell carcinoma through elevating C-MYC expression. Cell Physiol Biochem, 36, 100–110.
32.
LunA.T.L., ChenY., and SmythG.K. (2016). It's DE-licious: a recipe for differential expression analyses of RNA-seq experiments using quasi-likelihood methods in edgeR. In Statistical Genomics. Methods in Molecular Biology. E. Mathé and S. Davis, eds. (Humana Press, New York, NY), vol. 1418, pp. 391–416.
33.
MemczakS., JensM., ElefsiniotiA., TortiF., KruegerJ., RybakA., et al. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 495, 333–338.
34.
QuS., YangX., LiX., WangJ., GaoY., ShangR., et al. (2015). Circular RNA: a new star of noncoding RNAs. Cancer Lett, 365, 141–148.
35.
SiegelR.L., MillerK.D., FedewaS.A., AhnenD.J., MeesterR.G.S., BarziA., et al. (2017). Colorectal cancer statistics, 2017. CA Cancer J Clin, 67, 104–117.
36.
SzaboL., and SalzmanJ. (2016). Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet, 17, 679–692.
37.
TangX., ChenJ., WangY., and WangX. (2016). Gene cloning, expression and polyclonal antibody preparation of Rab3A for protein interaction analysis. SpringerPlus 5,1705.
38.
TrapnellC., PachterL., and SalzbergS.L. (2009). TopHat: discovering splice junctions with RNA-Seq. Bioinformatics, 25, 1105–1111.
39.
TrapnellC., WilliamsB., PerteaG., MortazaviA., KwanG., van BarenM., et al. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol, 28, 511–515.
40.
VillalbaM., EvansS.R., Vidal-VanaclochaF., and CalvoA. (2017). Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy. Cell Tissue Res, 370, 29–39.
41.
WangJ., LiX., LuL., HeL, HuH., and XuZ. (2018a). Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for human colorectal cancer. J Clin Lab Anal 32,e22379.
42.
WangZ., YanJ., ZouT., and GaoH. (2018b). MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc. Oncol Lett, 16, 2243–2250.
43.
XuC., XuM., WangW., and ZhangJ. (2016). Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction. Mol Med Rep, 13, 901–908.
44.
XuX.W., ZhengB.A., HuZ.M., QianZ.Y., HuangC.J., LiuX.Q., et al. (2017). Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b. Oncotarget, 8, 91674–91683.
45.
XuZ., YanY., ZengS., DaiS., ChenX., WeiJ., et al. (2018). Circular RNAs: clinical relevance in cancer. Oncotarget, 9, 1444–1460.
46.
YuG., WangL.G., HanY., and HeQ.Y. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS, 16, 284–287.
47.
YuP.N., YanM.D., LaiH.C., HuangR.L., ChouY.C., LinW.C., et al. (2014). Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells. Int J Cancer, 134, 542–551.
48.
ZhangR., XuJ., ZhaoJ., and WangX. (2018). Silencing of hsa_circ_0007534 suppresses proliferation and induces apoptosis in colorectal cancer cells. Eur Rev Med Pharmacol Sci, 22, 118–126.
49.
ZhangS., JinJ., TianX., and WuL. (2017). hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC. Oncotarget, 8, 104508–104524.
50.
ZhangX.O., DongR., ZhangY., ZhangJ.L., LuoZ., ZhangJ., et al. (2016). Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res, 26, 1277–1287.
51.
ZhuG.G., RisteliL., MäkinenM., RisteliJ., KauppilaA., and StenbäckF. (2015). Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer, 75, 1010–1017.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
